Nikhil Ananth
Associate
About
Nikhil is an Associate at F-Prime Capital and works across the healthcare sub-sectors including therapeutics, medical technology, and healthcare IT & services. Prior to joining F-Prime, Nikhil was an Associate at Audax Group in Boston, where he focused on private equity investments in healthcare.
Nikhil received a B.A. in Biology from the University of Pennsylvania and a B.S. in Economics from the Wharton School.
-
Eywa is a global generic pharmaceutical company engaged in research and development, manufacture, marketing, sale, and distribution of generic finished dosage formulations. Learn more at www.eywapharma.com.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Chennai, India
-
Year Invested
2016
-
Team
-
-
Invetx is a pioneer in creating novel, protein-based animal health therapeutics to transform standards of care in veterinary medicine. The company leverages a best-in-class, fully integrated biotechnology platform for the discovery, development, and manufacturing of veterinary monoclonal antibodies, and is developing a diverse product pipeline addressing chronic and severe diseases in the veterinary species. learn more at www.invetx.com.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Boston, MA
-
Year Invested
2022
-
Team
-
-
Ivenix is dedicated to eliminating infusion-related patient harm, uniquely positioned at the crossroads of healthcare IT and infusion delivery. Ivenix was acquired by Fresenius Kabi in 2022.
-
Category
- MedTech
-
Status
- Acquired
-
Location
Amesbury, MA
-
Year Invested
2011
-
Team
-
-
OZiva is a plant-based Clean Nutrition Brand. The brand’s core differentiator lies in building a nutrition & fitness ecosystem that combines the best of ancient sciences such as Ayurveda, modern micronutrients, and an instantaneous digital community altogether. Learn more at www.oziva.in.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Mumbai, India
-
Year Invested
2021
-
Team
-
-
Rallybio (NASDAQ: RLYB) is a biopharmaceutical company focused on identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Learn more at www.rallybio.com.
-
Category
- Therapeutics
-
Status
- Public
-
Location
Farmington, CT
-
Year Invested
2020
-
Team
-
